Americans are increasingly calling poison control centers over semaglutide, the active ingredient in popular weight loss drugs Ozempic and Wegovy. Most of these calls appear to concern potential overdoses of semaglutide and might be tied to a rise in compounded versions of the drug, which aren’t tested for their safety and can come in doses that vary greatly from the typical formulation.
Novo Nordisk Stock: Latest Insights Confirm Exceptionally Bullish Opportunity (NYSE:NVO) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Medtronic: The GLP-1 Drug Headwinds Are Overblown (NYSE:MDT) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.